Literature DB >> 27708908

A case of neutrophilic dermatosis who develop palpable purpura during the use of montelukast.

Gözde Yıldırım Çetin1, Hayriye Sayarlıoğlu2, Çiğdem Erhan3, Hasan Kahraman4, Harun Cıralık5, Mehmet Sayarlıoğlu6.   

Abstract

In this case report, we present a female patient with neutrophilic dermatosis (ND) occurring as palpable purpura after using montelukast. Neutrophilic dermatoses (NDs) are characterized by skin lesions in which mature neutrophils are predominantly located in the epidermis and dermis in the absence of any infective pathology. Classification of the NDs is based upon the recognition of clinical and pathologic features, as well as the identification of associated diseases, like Sweet's syndrome, pyoderma gangrenosum, generalized pustular psoriasis, and Behçet's disease. Cutaneous findings in NDs are variable and can include vesiculopustules, plaques, nodules, or ulcerations. Drug-induced NDs are not uncommon, but ND with palpable purpura is uncommon. The current patient appeared with a rare presentation as palpable purpura without vasculitis regarding ND. It is important that this is the first case report.

Entities:  

Keywords:  Neutrophilic dermatosis; leukotriene receptor antagonist; montelukast

Year:  2014        PMID: 27708908      PMCID: PMC5042251          DOI: 10.5152/eurjrheumatol.2014.140032

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


  7 in total

1.  AN ACUTE FEBRILE NEUTROPHILIC DERMATOSIS.

Authors:  R D SWEET
Journal:  Br J Dermatol       Date:  1964 Aug-Sep       Impact factor: 9.302

Review 2.  An approach to the diagnosis of neutrophilic dermatoses: A histopathological perspective.

Authors:  K C Nischal; Uday Khopkar
Journal:  Indian J Dermatol Venereol Leprol       Date:  2007 Jul-Aug       Impact factor: 2.545

Review 3.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

5.  A neutrophilic drug reaction to Clomid.

Authors:  N V Coots; C E McCoy; D L Gehlbach; L E Becker
Journal:  Cutis       Date:  1996-02

Review 6.  Sweet's syndrome (acute febrile neutrophilic dermatosis)

Authors:  P von den Driesch
Journal:  J Am Acad Dermatol       Date:  1994-10       Impact factor: 11.527

7.  Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients.

Authors:  Nicole M Rochet; Rahul N Chavan; Mark A Cappel; David A Wada; Lawrence E Gibson
Journal:  J Am Acad Dermatol       Date:  2013-07-23       Impact factor: 11.527

  7 in total
  2 in total

1.  Montelukast, an Antagonist of Cysteinyl Leukotriene Signaling, Impairs Burn Wound Healing.

Authors:  Alan V Nguyen; Michelle D Bagood; Marilyn Wang; Sofia E Caryotakis; Glendalyn Smith; Shannon Yee; Haitao Shen; R Rivkah Isseroff; Athena M Soulika
Journal:  Plast Reconstr Surg       Date:  2022-05-10       Impact factor: 5.169

2.  Neutrophilic dermatoses in a seronegative rheumatoid arthritis patient: A case report.

Authors:  Amel Awad IbnIdris Rodwan; Abdel Gaffar A Mohammed; Mohammed Elmujtba Adam Essa; Atif Elhadi Abdalla Babker; Ali Mohamed Abdelsatir; Elnour Mohammed Elagib
Journal:  Clin Case Rep       Date:  2022-01-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.